• OPEN AN ACCOUNT
Indian Indices
Sensex
73,033.78 1,109.10
( 1.54%)
Global Indices
Nasdaq
51,875.59 199.64
(0.39%)
Dow Jones
7,829.18 -3.36
(-0.04%)
Hang Seng
67,705.85 -1,325.07
(-1.92%)
Nikkei 225
10,649.29 -6.99
(-0.07%)
Forex
USD-INR
96.46 -0.32
(-0.33%)
EUR-INR
108.04 -0.35
(-0.32%)
GBP-INR
127.62 -0.24
(-0.19%)
JPY-INR
0.61 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Vanta Bioscience Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
540729
INE695X01011
29.8818898
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
120.12
14.52
EPS(TTM)
Face Value()
Div & Yield %
0.17
10
0
 

Engineers India slips after Q4 PAT slides 30% YoY to Rs 195 cr
May 22,2026
Profit before tax came in at Rs 242.01 crore for the March 2026 quarter, marking a 31.57% year-on-year drop.

Total expenses rose 9.05% YoY to Rs 785.63 crore during the quarter from Rs 720.45 crore in Q4 FY25. Construction materials and equipment expenses rose 52.69% YoY to Rs 122.52 crore. Employee benefits expenses increased 2.16% YoY to Rs 281.13 crore during the period under review.

On the segmental front, revenue from consultancy & engineering projects was Rs 516.71 crore (down 7.99% YoY), and revenue from turnkey projects was Rs 409.58 crore (down 8.71% YoY) during the period under review.

The company’s board recommended a final dividend of Rs 2.50 per equity share of face value Rs 5 each (50%) for FY26, subject to approval of shareholders at the ensuing Annual General Meeting (AGM).

Engineers India, a Navratna public sector enterprise, is an engineering consultancy and EPC company. As of March 2026, the Government of India held a 51.32% stake in the company.